Gujarat Terce Laboratories Ltd

NSE: GUJTERC · BSE: 524314 · Pharmaceuticals & Biotechnology · 19 announcements

Share price: ₹42.46
Market cap: ₹31.51 Cr
Revenue (annual): ₹47.47 Cr
Net profit (annual): ₹2.20 Cr
P/E (TTM): 15.7×Sector 43.8×
Promoter holding: 40.03%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 1 Board Meeting Date 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

5 Nov 2026 17:03 IST BSE

Acquisition

Gujarat Terce Laboratories Acquisition Worth ₹3.23 Cr

Gujarat Terce Laboratories agreed to buy its corporate office premises 'Swati18' in Ahmedabad. The purchase is for Rs 3.23 Crore, excluding taxes and charges.

Value: ₹3.23 Cr

Open announcement → Read the filing ↗

5 Nov 2026 16:49 IST BSE

Financial Results

Gujarat Terce Laboratories Q2 FY27 Results: Net Profit ₹1.3 Cr, Down 7.1% YoY

Gujarat Terce approved unaudited standalone results for quarter and half year ended September 2026. Q2 profit was 131.92 lakhs against a Q1 loss of 17.81 lakhs.

Key figure: Net profit ₹1.3 Cr · -7.1% YoY

Open full results → Read the filing ↗

29 Oct 2026 12:11 IST BSE

Board Meeting Date

Gujarat Terce Laboratories Board Meeting Date

Gujarat Terce Laboratories will hold a board meeting on November 5, 2026 to consider unaudited standalone results for September 2026. The trading window stays closed until November 7, 2026.

Open announcement → Read the filing ↗